TSE:2269 | 1/22/2025 | "The Bath" has acquired an international authentication program "informed protein certification" that verifies the reliability of the protein mass display in the product | https://www.meiji.co.jp/corporate/pressrelease/2025/01_10/ |
TSE:4506 | 1/22/2025 | "Healthy activity report 2024 Environmental conservation activity, social contribution activity" is posted on a healthy compass | https://www.sumitomo-pharma.co.jp/sukoyaka/smp/report2024_1/index.html |
TSE:4507 | 1/22/2025 | Started a business tie -up for the creation of an innovative drug and healthcare industry that utilizes Hitachi, Hitachi, Hitachi, data and generated AI, etc. | https://www.shionogi.com/jp/ja/news/2025/01/20250122-3.html |
TSE:4507 | 1/22/2025 | "Resource Recycling Project" aims to horizontal recycling of label mounts is awarded WORLDSTAR AWARDS 2025 | https://www.shionogi.com/jp/ja/news/2025/01/20250122.html |
TSE:4507 | 1/22/2025 | About the acceptance and government stockpile of the new drug approval in Taiwan of the new colon virus infection treatment. | https://www.shionogi.com/jp/ja/news/2025/01/20250122_2.html |
TSE:4516 | 1/21/2025 | Highly evaluated by IR site evaluation of three major organizations | https://www.nippon-shinyaku.co.jp/news/news.php?id=3279 |
TSE:4547 | 1/21/2025 | Notice of acquiring sales approval in Korea of the spleen tyrocinase inhibitor "Hostamatinib" | https://www.kissei.co.jp/news/2025/20250121-4980.html |
TSE:4578 | 1/21/2025 | Otsuka Pharmaceutical "Total Conditioning Handbook for Welbying" Supports the exhibition of public life performance | https://www.otsuka.co.jp/company/newsreleases/2025/20250121_1.html |
TSE:4901 | 1/21/2025 | Hybrid Instant Camera "Instax Wide Evo (Instax Wide Evo) ™" newly released (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/12026 |
TSE:4901 | 1/21/2025 | Limited release of Instax Mini Evo ™ Pink (Fujifilm) | https://www.fujifilm.com/jp/ja/news/list/12018 |
JNJ | 1/21/2025 | SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression | https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression |
JNJ | 1/21/2025 | European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer | https://www.jnj.com/media-center/press-releases/european-commission-approves-lazcluze-lazertinib-in-combination-with-rybrevant-amivantamab-for-the-first-line-treatment-of-patients-with-egfr-mutated-advanced-non-small-cell-lung-cancer |
TSE:4568 | 1/21/2025 | Notice of the establishment of a state -of -the -art smartly search glow that is responsible for drug discovery research in San Diego in the United States (145.3KB) PDF files are displayed in another window. | https://www.daiichisankyo.co.jp/files/news/pressrelease/pdf/202501/20250121_J.pdf |
TSE:2269 | 1/20/2025 | Winter only!The first flavor of the "adult Essel Super Cup" series, which has a four -layer structure that combines ice and ingredients, also appears "Meiji Essel Super Cup Adult Label" and Chocolat / February 27, February 27, February 2710 days limited n | https://www.meiji.co.jp/corporate/pressrelease/2025/01_06/ |
TSE:4151 | 1/20/2025 | Notice of the Prime Minister Award at the 7th Japan Medical Research and Development Award (614KB) | https://www.kyowakirin.co.jp/pressroom/news_releases/2025/pdf/20250120_01.pdf |